Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-04-01 16:09:16 ET · period of report 2025-07-31 · accession 0001628280-26-022792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-01 16:09 | 2025-07-31 | TLSI | MATLIN DAVID J | Dir | C - Cnv Deriv | $0.00 | +330.0K | 1.27M | +35% | $0 |
| D | 2026-04-01 16:09 | 2025-07-31 | TLSI | MATLIN DAVID J | Dir | C - Cnv Deriv | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-31 | C | A | 330,000 | $0.00 | 1,271,944 | D | — | — | (F1) Represents shares received upon conversion of the Series A Preferred Stock (the "Preferred Stock") reported in Table II. |
| 2 | Derivative | Series A Preferred Stock | 2025-07-31 | C | D | 100,000 | $0.00 | 0 | D | $4.00 · — to — | 330,000 Common Stock | (F2) Represents conversion price pursuant to an offer (the "Offer") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share. (F3) On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. (F3) On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. (F3) On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. (F3) On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. (F3) On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer. |